EDGEWISE THERAPEUTICS INC (EWTX) Forecast, Price Target & Analyst Ratings

NASDAQ:EWTXUS28036F1057

Current stock price

30.64 USD
+0.84 (+2.82%)
At close:
30.64 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EDGEWISE THERAPEUTICS INC (EWTX).

Forecast Snapshot

Consensus Price Target

Price Target
$38.93
+ 27.06% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.50
Revenue Estimate

ChartMill Buy Consensus

Rating
83.33%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$38.93
Upside
+ 27.06%
From current price of $30.64 to mean target of $38.93, Based on 18 analyst forecasts
Low
$16.16
Median
$42.33
High
$53.55

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

18 Wall Street analysts provided a forecast for the next 12 months for EWTX. The average price target is 38.93 USD. This implies a price increase of 27.06% is expected in the next year compared to the current price of 30.64.

Analyst Ratings & History

Current Analyst Ratings

EWTX Current Analyst RatingEWTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

EWTX Historical Analyst RatingsEWTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
83.33%
EWTX was analyzed by 18 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about EWTX.
In the previous month the buy percentage consensus was at a similar level.
EWTX was analyzed by 18 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-17WedbushReiterate Outperform -> Outperform
2026-03-17JP MorganMaintains Overweight -> Overweight
2026-02-27Evercore ISI GroupMaintains Outperform -> Outperform
2025-11-14JP MorganMaintains Overweight -> Overweight
2025-11-07RBC CapitalMaintains Outperform -> Outperform
2025-11-07WedbushMaintains Outperform -> Outperform
2025-09-25Goldman SachsInitiate Neutral
2025-08-19JP MorganMaintains Overweight -> Overweight
2025-08-08RBC CapitalMaintains Outperform -> Outperform
2025-06-30HC Wainwright & Co.Initiate Buy
2025-06-05RBC CapitalReiterate Outperform -> Outperform
2025-04-21WedbushMaintains Outperform -> Outperform
2025-04-03ScotiaBankDowngrade Sector Outperform -> Sector Perform
2025-04-03RBC CapitalMaintains Outperform -> Outperform
2025-04-02Piper SandlerMaintains Overweight -> Overweight
2025-03-07ScotiaBankInitiate Sector Outperform
2025-03-04RBC CapitalReiterate Outperform -> Outperform
2025-01-22StifelInitiate Hold
2024-12-17Evercore ISI GroupMaintains Outperform -> Outperform
2024-11-27Truist SecuritiesMaintains Buy -> Buy
2024-11-22Evercore ISI GroupInitiate Outperform
2024-11-08WedbushMaintains Outperform -> Outperform
2024-10-11Piper SandlerMaintains Overweight -> Overweight
2024-09-20RBC CapitalMaintains Outperform -> Outperform
2024-09-19Truist SecuritiesMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.50
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-15.58%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-8.28%
EPS (3 Months)
-8.28%

Next Earnings Summary

EWTX is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.5 USD and the consensus revenue estimate is 0 USD.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
EWTX revenue by date.EWTX revenue by date.
N/AN/AN/A
710.36%
N/A
162.89%
N/A
128.58%
N/A
67.83%
N/A
58.84%
N/A
27.24%
EBITDA
YoY % growth
EWTX ebitda by date.EWTX ebitda by date.
-9.8M-17M
-73.47%
-42.95M
-152.65%
-71.29M
-65.98%
-112.806M
-58.24%
-156.763M
-38.97%
-189.322M
-20.77%
N/A
-15.68%
N/A
-13.99%
N/A
15.02%
N/A
177.28%
N/A
219.36%
N/A
62.96%
N/A
72.77%
N/A
2.31%
EBIT
YoY % growth
EWTX ebit by date.EWTX ebit by date.
-9.92M-17.19M
-73.29%
-43.22M
-151.43%
-71.66M
-65.80%
-114.357M
-59.58%
-158.832M
-38.89%
-191.406M
-20.51%
N/A
-30.80%
N/A
-13.67%
N/A
19.11%
N/A
48.91%
N/A
240.40%
N/A
166.63%
N/A
109.13%
N/A
49.22%
Operating Margin
EWTX operating margin by date.EWTX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
EWTX eps by date.EWTX eps by date.
N/AN/A-0.87-1.27
-45.98%
-1.58
-24.41%
-1.45
8.23%
-1.63
-12.41%
N/A
-31.92%
N/A
-12.28%
N/A
23.59%
N/A
32.43%
N/A
156.14%
N/A
229.45%
N/A
129.87%
N/A
62.80%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.50
-15.58%
-0.51
-50.82%
-0.51
-29.90%
-0.54
-15.46%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
-53.833M
-18.45%
-53.648M
-29.04%
-52.79M
-16.54%
-55.42M
-2.83%
EBIT
Q2Q % growth
-57.832M
-25.83%
-60.74M
-42.55%
-58.71M
-25.29%
-64.115M
-14.53%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

EWTX Yearly Revenue VS EstimatesEWTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
EWTX Yearly EPS VS EstimatesEWTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-4.21%
EPS Next 5 Year
19.43%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-3.78%
EBIT Next 5 Year
36.61%

EDGEWISE THERAPEUTICS INC / EWTX Forecast FAQ

What is the price target for EWTX stock?

18 analysts have analysed EWTX and the average price target is 38.93 USD. This implies a price increase of 27.06% is expected in the next year compared to the current price of 30.64.

When does EDGEWISE THERAPEUTICS INC (EWTX) report earnings?

EDGEWISE THERAPEUTICS INC (EWTX) will report earnings on 2026-05-06.

Can you provide the consensus estimates for EDGEWISE THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of EDGEWISE THERAPEUTICS INC (EWTX) is -0.5 USD and the consensus revenue estimate is 0 USD.

How many analysts cover EDGEWISE THERAPEUTICS INC (EWTX) stock?

The number of analysts covering EDGEWISE THERAPEUTICS INC (EWTX) is 18.